Christine Y. Lu

6.4k total citations
239 papers, 4.1k citations indexed

About

Christine Y. Lu is a scholar working on Economics and Econometrics, Clinical Psychology and Genetics. According to data from OpenAlex, Christine Y. Lu has authored 239 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Economics and Econometrics, 32 papers in Clinical Psychology and 29 papers in Genetics. Recurrent topics in Christine Y. Lu's work include Health Systems, Economic Evaluations, Quality of Life (59 papers), Pharmaceutical Economics and Policy (33 papers) and Suicide and Self-Harm Studies (23 papers). Christine Y. Lu is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (59 papers), Pharmaceutical Economics and Policy (33 papers) and Suicide and Self-Harm Studies (23 papers). Christine Y. Lu collaborates with scholars based in United States, Australia and Taiwan. Christine Y. Lu's co-authors include Dennis Ross‐Degnan, Stephen B. Soumerai, Jason C. Hsu, Gregory E. Simon, Brian K. Ahmedani, Ashli Owen‐Smith, Zaheer Uddin Babar, Beth E. Waitzfelder, Rebecca C. Rossom and Arne Beck and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Christine Y. Lu

220 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine Y. Lu United States 33 998 712 518 508 384 239 4.1k
Robert Temple United States 32 946 0.9× 302 0.4× 605 1.2× 361 0.7× 381 1.0× 78 6.9k
Daniel Hind United Kingdom 36 468 0.5× 461 0.6× 477 0.9× 655 1.3× 475 1.2× 155 5.2k
Lisa M. LaVange United States 37 663 0.7× 658 0.9× 1.2k 2.4× 717 1.4× 830 2.2× 86 7.5k
Louise Falzon United States 40 340 0.3× 762 1.1× 535 1.0× 1.0k 2.0× 504 1.3× 120 5.9k
Ulf Bergman Sweden 43 1.2k 1.2× 603 0.8× 760 1.5× 537 1.1× 614 1.6× 178 6.6k
Rajesh Balkrishnan United States 39 889 0.9× 300 0.4× 662 1.3× 1.4k 2.7× 401 1.0× 195 6.9k
Carlos King Ho Wong Hong Kong 39 817 0.8× 556 0.8× 365 0.7× 864 1.7× 982 2.6× 348 6.5k
Morten Andersen Denmark 44 898 0.9× 280 0.4× 997 1.9× 414 0.8× 537 1.4× 211 6.6k
Andrew Clegg United Kingdom 42 440 0.4× 368 0.5× 654 1.3× 694 1.4× 503 1.3× 135 5.5k
Nigel Stallard United Kingdom 36 789 0.8× 316 0.4× 286 0.6× 363 0.7× 249 0.6× 193 4.4k

Countries citing papers authored by Christine Y. Lu

Since Specialization
Citations

This map shows the geographic impact of Christine Y. Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Y. Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Y. Lu more than expected).

Fields of papers citing papers by Christine Y. Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Y. Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Y. Lu. The network helps show where Christine Y. Lu may publish in the future.

Co-authorship network of co-authors of Christine Y. Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Y. Lu. A scholar is included among the top collaborators of Christine Y. Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Y. Lu. Christine Y. Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Shwu‐Jiuan, Phung-Anh Nguyen, Chun‐Yao Huang, et al.. (2025). Early prediction of cardiovascular events following treatments in female breast cancer patients: Application of real-world data and artificial intelligence. The Breast. 81. 104438–104438.
2.
3.
Mansur, Arian, et al.. (2025). Disparities in heart failure deaths among people with diabetes in the United States: 1999–2020. Diabetes Obesity and Metabolism. 27(6). 2977–2984. 3 indexed citations
4.
5.
Lu, Christine Y., Sarah N. Hilmer, Yun‐Hee Jeon, et al.. (2025). Treatment modifiers and predictors of risperidone response in dementia: An individual participant data meta‐analysis of six randomized controlled trials. Alzheimer s & Dementia. 21(9). e70665–e70665. 1 indexed citations
6.
Lu, Christine Y., et al.. (2025). Effectiveness and Safety of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review of Real-World Studies. Current Oncology Reports. 27(6). 687–702. 1 indexed citations
7.
Nguyen, Phung‐Anh, Min‐Huei Hsu, Tzu‐Hao Chang, et al.. (2024). Taipei Medical University Clinical Research Database: a collaborative hospital EHR database aligned with international common data standards. BMJ Health & Care Informatics. 31(1). e100890–e100890. 6 indexed citations
8.
Hendricks‐Sturrup, Rachele, et al.. (2024). Applying an ELSI lens to real-world data and novel genomic insights for personalized mental healthcare. Frontiers in Genetics. 15. 1444084–1444084. 1 indexed citations
9.
Kahn, Geoffrey, Elizabeth Lockhart, Gregory E. Simon, et al.. (2023). Recorded Diagnosis of Gender Identity Disorder Is Strongly Associated with Suicide Mortality. Transgender Health. 9(5). 454–458.
10.
Green, Robert C., Catherine Hajek, Eric Larson, et al.. (2023). SLCO1B1 Gene-Based Clinical Decision Support Reduces Statin-Associated Muscle Symptoms Risk With Simvastatin. Pharmacogenomics. 24(7). 399–409. 4 indexed citations
11.
Christensen, Kurt D., Pamela M. McMahon, Jennifer M. Yeh, et al.. (2023). Benefits, harms, and costs of newborn genetic screening for hypertrophic cardiomyopathy: Estimates from the PreEMPT model. Genetics in Medicine. 25(4). 100797–100797. 4 indexed citations
12.
Hendricks‐Sturrup, Rachele, et al.. (2021). Patient-Reported Outcomes following Genetic Testing for Familial Hypercholesterolemia, Breast and Ovarian Cancer Syndrome, and Lynch Syndrome: A Systematic Review. Journal of Personalized Medicine. 11(9). 850–850. 1 indexed citations
13.
Wharam, J. Frank, Jamie Wallace, Fang Zhang, et al.. (2021). Diabetes Microvascular Disease Diagnosis and Treatment After High-Deductible Health Plan Enrollment. Diabetes Care. 45(8). 1754–1761. 3 indexed citations
14.
Hsu, Jason C., et al.. (2020). Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series study. BMJ Open. 10(5). e033427–e033427. 15 indexed citations
15.
Prabhakar, Deepak, Edward L. Peterson, Yong Hu, et al.. (2020). Serious Suicide Attempts and Risk of Suicide Death. Crisis. 42(5). 343–350. 4 indexed citations
16.
Gavan, Sean P., Christine Y. Lu, & Katherine Payne. (2019). Assessing the Joint Value of Genomic-Based Diagnostic Tests and Gene Therapies. Journal of Personalized Medicine. 9(2). 28–28. 7 indexed citations
17.
Daniels, Benjamin, Sarah J. Lord, Belinda E. Kiely, et al.. (2017). Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort. BMJ Open. 7(1). e014439–e014439. 16 indexed citations
18.
Ahmedani, Brian K., Edward L. Peterson, Yong Hu, et al.. (2017). Major Physical Health Conditions and Risk of Suicide. American Journal of Preventive Medicine. 53(3). 308–315. 181 indexed citations
19.
Hsu, Jason C. & Christine Y. Lu. (2016). Longitudinal trends in use and costs of targeted therapies for common cancers in Taiwan: a retrospective observational study. BMJ Open. 6(6). e011322–e011322. 15 indexed citations
20.
Adams, Alyce S., Fang Zhang, Robert F. LeCates, et al.. (2009). Prior Authorization for Antidepressants in Medicaid. Archives of Internal Medicine. 169(8). 750–750. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Temple Breakdown of academic impact, for papers by Daniel Hind Breakdown of academic impact, for papers by Lisa M. LaVange Breakdown of academic impact, for papers by Louise Falzon Breakdown of academic impact, for papers by Ulf Bergman Breakdown of academic impact, for papers by Rajesh Balkrishnan Breakdown of academic impact, for papers by Carlos King Ho Wong Breakdown of academic impact, for papers by Morten Andersen Breakdown of academic impact, for papers by Andrew Clegg Breakdown of academic impact, for papers by Nigel Stallard
Rankless by CCL
2026